CDC42 and Alzheimer disease: RhoA was found to have the opposite effect: a decrease of activity in AD brains; however, RhoA is similarly involved in Aβ peptide production, potentially in cooperation with Rac1 and Cdc42 (Mendoza-Naranjo et al., 2007).